Dexmedetomidine perineurally
PreclinicalSmall molecule
Dexmedetomidine perineurally is one of 4 small molecule programs targeting Epidural Analgesia. It is currently in Preclinical.
1
Indications
6
Total Trials
0
Active Trials
3
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
7 competitors in Epidural Analgesia
#DrugCompanyPhaseTrials
1Intrathecal Morphine
Pacira Pharmaceuticals, IncPhase 3
EXPAREL
Pacira Pharmaceuticals, IncPreclinical
Bupivicaine
TThomas Jefferson University
Preclinical
Dexmedetomidine perineurally
ZZealand University Hospital
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Dexmedetomidine3 trials
Combined Use of Dexmedetomidine and Hydrocortisone to Prevent New Onset AF After CABG Surgery
Unknown status·—·Phase 1·NCT05674253·248 enrolled
Comparative Study Between Dexmedetomidine and Fentanyl as Adjuvants to Bupivacaine
Completed·—·Phase 4·NCT06864416·20 enrolled
Epidural Analgesia1 trial
Lumbar Epidural Analgesia Versus Local Anesthesia With Dexmedetomidine Infusion in Endoscopic Lumbar Discectomy
Completed·—·N/A·NCT05850455·78 enrolled
Abdominal Surgeries1 trial
Comparative Study Between Two Adjuvant Drugs to Bupivacaine for Post-operative Epidural Analgesia in Abdominal Surgeries
Unknown status·—·Phase 4·NCT05323214·75 enrolled
Postoperative Analgesia1 trial
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- ZZealand University Hospital